Skip to main content
Pharmaceutical Manufacturing

Territory Redesign Unlocks 28% Coverage Efficiency

How SNIPER analytics transformed a fragmented territory structure into a revenue-generating machine for a multinational pharmaceutical company.

SNIPER Her-Zone

+28%

Coverage Efficiency

More high-potential customers reached per rep day

Reduced to 2:1

Territory Variance

Down from 4:1 imbalance

67 days

Time to Implementation

From analysis to field deployment

The Challenge

Territory structures evolved organically over years, creating overlapping coverage in urban areas and critical gaps in high-potential rural regions. Sales variance between territories exceeded 4:1, with top performers carrying unsustainable workloads while others had insufficient customer bases.

Our Solution

Deployed SNIPER analytics to map customer-level prescriber potential against current coverage. Rebuilt 47 territories using Her-Zone geographic intelligence, balancing workload while maximising high-potential customer access.

"For the first time in a decade, our territories make commercial sense. Reps are no longer fighting over the same doctors or driving past customers to reach their patch."

Commercial Director

Multinational Pharmaceutical

The Challenge

After 15 years of organic growth, acquisitions, and field force changes, this multinational pharmaceutical company found itself with a territory structure that no longer reflected commercial reality.

Key issues identified:

  • Urban territories overlapped significantly, with multiple reps calling on the same prescribers
  • High-potential rural regions had no dedicated coverage
  • Sales variance between best and worst territories exceeded 4:1
  • Top performers were overworked; others had insufficient customer bases
  • Travel time consumed up to 40% of some reps’ working week

The company had attempted territory redesign twice before, but both efforts failed due to rep resistance and insufficient data to justify the changes.

Our Approach

Phase 1: Customer-Level Intelligence (Weeks 1-3)

Using SNIPER analytics, we mapped every customer at prescriber level, scoring:

  • Current revenue contribution
  • Prescriber potential (based on speciality, patient volume, prescribing behaviour)
  • Competitive position
  • Geographic accessibility

This analysis revealed that 34% of current call activity was directed at customers with limited growth potential, while 22% of high-potential prescribers received zero coverage.

Phase 2: Geographic Optimisation (Weeks 4-6)

Her-Zone geographic intelligence overlaid customer data onto actual road networks and travel times. This exposed:

  • Territories where reps drove past high-potential customers daily
  • Clusters of prescribers that could be reassigned without adding travel time
  • Natural geographic boundaries that aligned with prescriber density

Phase 3: Workload Balancing (Weeks 7-8)

New territories were designed with three core principles:

  1. Equal opportunity: Each territory had comparable revenue potential
  2. Achievable coverage: Call plans could be executed within realistic travel constraints
  3. Growth headroom: Every territory included high-potential development customers

Phase 4: Change Management (Weeks 9-10)

We presented the redesign to each rep individually, showing:

  • Why their current territory was underperforming or unsustainable
  • The commercial opportunity in their new assignment
  • Specific customers they would gain (with prescriber profiles)
  • Transition support and handover protocols

The Results

Within 90 days of implementation:

  • 28% improvement in coverage efficiency (high-potential customers reached per rep day)
  • Territory variance reduced to 2:1 (down from 4:1)
  • 67 days from project start to field deployment
  • Zero rep attrition during transition

Six months post-implementation, the client reported a 14% increase in sales from the same-size field force.

Key Insight

Territory redesign fails when it’s treated as a mapping exercise. Success requires customer-level intelligence that makes the commercial case undeniable -to leadership and to the reps whose lives will change.

Facing a Similar Challenge?

This case study represents real transformation work. If you're dealing with pharmaceutical manufacturing challenges, let's discuss how we can help.